Meeting
2011 Breast Cancer Symposium
Axillary node staging for microinvasive breast cancer: Is it justified?
Authors
J. M. Lyons III
Memorial Sloan-Kettering Cancer Center, New York, NY
J. M. Lyons III, M. Stempel , K. J. Van Zee , H. S. Cody III
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A
Track
Detection, Screening, and Imaging
Sub Track
Axillary/Sentinel Nodes
Citation
J Clin Oncol 29, 2011 (suppl 27; abstr 7)
Abstract #
7
Poster Bd #
A5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Association of minimizing the false negative rate of axillary staging surgery in patients with cN1 breast cancer after neoadjuvant chemotherapy with surgical overtreatment.
First Author: Alison Laws
Poster
2011 Breast Cancer Symposium
Prognosis and non-sentinel lymph node status of the breast cancer patients with micrometastatic sentinel lymph nodes.
First Author: M. Takahashi
Poster
2024 ASCO Annual Meeting
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
First Author: Maggie Banys-Paluchowski
Poster
2023 ASCO Breakthrough
Risk assessment, prevention and early detection of breast cancer related lymphedema: Objective measurements and patient reported outcomes.
First Author: Anshumi Desai